Medicare Enrolled

Dr. Reed Levine, M.D

Neurology · Pasadena, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1017 S FAIR OAKS AVE, Pasadena, CA 91105
6264036200
In practice since 2007 (18 years)
NPI: 1386844868 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Levine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levine? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Levine

Dr. Reed Levine is a neurology specialist in Pasadena, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Levine performed 2,031 Medicare services across 723 unique beneficiaries.

Between the years covered by Open Payments, Dr. Levine received a total of $119,005 from 53 pharmaceutical and/or device companies across 1145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Levine is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 21% volume in CA $119,005 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,031
Medicare services
Top 21% in CA for neurology
723
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,137 $97 $427
Psychological or neuropsychological test, first 30 minutes
Administration of psychological or neuropsychological testing for the first 30 minutes.
371 $34 $150
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
221 $60 $186
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
90 $71 $303
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
42 $120 $553
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
35 $79 $921
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
24 $109 $611
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
23 $64 $312
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $37 $190
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
19 $156 $1,575
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
19 $49 $884
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $125 $599
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
13 $95 $874
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$119,005
Total received (2018-2024)
Avg $17,001/year across 7 years
Top 6% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,145
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67,216 (56.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,139 (23.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,651 (19.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,489
2023
$3,748
2022
$4,748
2021
$10,538
2020
$6,116
2019
$22,177
2018
$66,188

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$2,788
Spinal Simplicity, LLC
$811
Boston Scientific Corporation
$733
Abbott Laboratories
$182
Collegium Pharmaceutical, Inc.
$173
ABBVIE INC.
$152
BIOTRONIK NRO, Inc.
$142
Nalu Medical, Inc.
$107
Forte Bio-Pharma LLC
$89
Virtus Pharmaceuticals LLC
$62
Lundbeck LLC
$54
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$50
PFIZER INC.
$50
SPR Therapeutics, Inc
$28
Curonix LLC
$25
Lilly USA, LLC
$25
SCILEX PHARMACEUTICALS INC.
$19
Top 3 companies account for 78.9% of 2024 payments
All-time payments by company (2018-2024) ›
Assertio Therapeutics, Inc.
$41,058
BioDelivery Sciences International, Inc.
$22,210
Biogen, Inc.
$15,507
Abbott Laboratories
$7,432
US WorldMeds, LLC
$6,498
Medtronic, Inc.
$5,205
Boston Scientific Corporation
$2,763
Spinal Simplicity, LLC
$2,624
Nuvectra Corporation
$2,555
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$2,398
RedHill Biopharma Inc.
$1,717
USWM, LLC
$1,550
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$963
Collegium Pharmaceutical, Inc.
$866
SPR Therapeutics, Inc
$853
Nevro Corp.
$486
Nalu Medical, Inc.
$436
ABBVIE INC.
$419
AbbVie Inc.
$298
Biohaven Pharmaceuticals, Inc.
$249
Novartis Pharmaceuticals Corporation
$217
Forte Bio-Pharma LLC
$208
Horizon Therapeutics plc
$189
PFIZER INC.
$187
Scilex Pharmaceuticals Inc.
$173
PAINTEQ LLC
$152
Lilly USA, LLC
$143
BIOTRONIK NRO, Inc.
$142
ASSERTIO THERAPEUTICS, Inc.
$126
Almatica Pharma LLC
$126
BOSTON SCIENTIFIC CORPORATION
$120
Lundbeck LLC
$110
Virtus Pharmaceuticals LLC
$108
Biohaven Pharmaceutical Holding Company Ltd.
$107
Amgen Inc.
$104
Teva Pharmaceuticals USA, Inc.
$100
Allergan, Inc.
$84
Curonix LLC
$51
PIRAMAL CRITICAL CARE
$49
Allergan Inc.
$42
Bioventus LLC
$39
Hikma Pharmaceuticals USA
$38
Vertical Pharmaceuticals, LLC
$36
Medtronic USA, Inc.
$36
GRT US Holding, Inc.
$35
SCILEX PHARMACEUTICALS INC.
$34
Shionogi Inc
$32
Globus Medical, Inc.
$26
Ipsen Biopharmaceuticals, Inc
$24
SI-BONE, INC.
$22
IBSA Pharma Inc.
$22
AstraZeneca Pharmaceuticals LP
$19
Saluda Medical Americas, Inc.
$18
Top 3 companies account for 66.2% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AIMOVIG · AJOVY · Aimovig · Algovita · Allocate · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · Cambia · DUEXIS · Durolane · Dysport · EMGALITY · ETERNA · Evoke SCS · GABLOFEN · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GILENYA · GRALISE · General - Pain Management · Gralise · HA MINUTEMAN G3-R · INTELLIS ADAPTIVESTIM · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LEVORPHANOL TARTRATE · LIBERTY SI · LOREEV XR · LORZONE · LUCEMYRA · LYRICA · Licart · Lucemyra · Lucemyra/Lofexidine · MOVANTIK · Movantik · NA · NALOCET · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · OCTRODE · Octrode SCS Leads · Omnia · PAINTEQ · PENNSAID · PENTA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PRODIGY · PROLATE · Penta SCS Leads · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prospera · QULIPTA · Qutenza · RAYOS · RELISTOR · SCS IPGs · SPECIFY · SPECTRA WAVEWRITER · SPINRAZA · SPRINT PNS System · SUPERION · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion · Superion Indirect Decompression System · Symproic · UBRELVY · VANTA ADAPTIVESTIM · VERIFLEX · VYEPTI · Vanta · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in CA.

Looking for a neurology specialist in Pasadena?
Compare neurologists in the Pasadena area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
561
Per 100K population
5.7
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Levine is a clinical cardiology specialist, with above-average Medicare volume (top 21% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Levine experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Levine performed 1,137 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levine receive payments from pharmaceutical companies?
Yes. Dr. Levine received a total of $119,005 from 53 companies across 1,145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levine's costs compare to other neurologists in Pasadena?
Dr. Levine's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →